The Prevalence of the Alpha-1 Antitrypsin Deficiency in Patients with Chronic Obstructive Pulmonary Disease

Alpha 1-antitrypsin deficiency (AATD) is one of the genetic risk factors in the patients suffering from chronic obstructive pulmonary disease (COPD). The exact number of Iranians suffering from this disease is yet not known. Therefore, the aim of this study was to determine the prevalence of the deficiency of AAT enzyme in patients suffering from COPD. The topical test of AAT serum was conducted on 125 patients affected by COPD who had referred to Ekbatan Hospital of Hamadan in 2007. The diagnoses of COPD in these patients dad been confirmed through history and spirometerty test before and after bronchodilator inhalation and the outcomes had been confirmed based on GOLD regulations. In other words, after separation of serum from blood, the specific antibody of AAT was added to the sample. The AAT serum level was read according to nephelometry measurement and the results were given in g/L. The gathered data were then analyzed using SPSS software program and statistical tests such as T-test and 2.